Safe sequencing system

Patent metadata

Field	Value
Publication number	US-12534759-B2
Application number	US-202418738910-A
Country	US
Kind code	B2
Filing date	Jun 10, 2024
Priority date	Apr 15, 2011
Publication date	Jan 27, 2026
Grant date	Jan 27, 2026

Abstract

The identification of mutations that are present in a small fraction of DNA templates is essential for progress in several areas of biomedical research. Though massively parallel sequencing instruments are in principle well-suited to this task, the error rates in such instruments are generally too high to allow confident identification of rare variants. We here describe an approach that can substantially increase the sensitivity of massively parallel sequencing instruments for this purpose. One example of this approach, called “Safe-SeqS” for (Safe-Sequencing System) includes (i) assignment of a unique identifier (UID) to each template molecule; (ii) amplification of each uniquely tagged template molecule to create UID-families; and (iii) redundant sequencing of the amplification products. PCR fragments with the same UID are truly mutant (“super-mutants”) if ≥95% of them contain the identical mutation. We illustrate the utility of this approach for determining the fidelity of a polymerase, the accuracy of oligonucleotides synthesized in vitro, and the prevalence of mutations in the nuclear and mitochondrial genomes of normal cells.

First claim

We claim:

1 . A method comprising:
a) attaching paired-end adapters to first and second ends of an initial double-stranded template nucleic acid molecule (IDSTNM) having top and bottom strands to form an adapted fragment, wherein a first endogenous UID is at said first end of said IDSTNM and a second endogenous UID is at said second end of said IDSTNM; b) amplifying said adapted fragment such that a plurality of double-stranded amplicons are generated that each comprise a first paired-end adapter at one end and a second paired-end adapter at the other end that is different from said first paired-end adapter, c) subjecting said plurality of double-stranded amplicons to paired-end sequencing on a massively parallel sequencer using a first primer to said first paired-end adapter and a second primer to said second paired-end adapter to generate the following reads:
i) first primer top strand reads and second primer top strand reads, and
ii) first primer bottom strand reads and second primer bottom strand;
d) differentiating said top and bottom strands of said IDSTNM based on the observed orientation and order of said first and second endogenous UIDs as they appear in said reads when sequence information is obtained from said paired-end sequencing; e) grouping said reads by chromosome position of said first and second endogenous UIDs yielding:
i) a first family comprising said first primer top strand reads and said second primer top strand reads, and
ii) a second family comprising said first primer bottom strand reads and said second primer bottom strand reads;
f) comparing nucleotide sequences between members of said first family, and comparing nucleotide sequences between members of said second family; and g) identifying a nucleotide sequence as accurately representing said top strand or bottom strand of said initial double-stranded template molecule when at least 50% of members of said first family, or said second family, contain the sequence.

2 . The method of claim 1 , wherein said first and second endogenous UIDs are 2 to 1000 bases in length.

3 . The method of claim 1 , wherein said first and second endogenous UIDs are 4 to 400 bases in length.

4 . The method of claim 1 , wherein said at least 50% is at least 70%.

5 . The method of claim 1 , wherein said attaching adapters is performed by ligation.

6 . The method of claim 1 , wherein said amplification employs primers complementary to at least a portion of said paired-end adapters.

7 . The method of claim 6 , wherein said primers comprise an indexing and/or grafting sequence.

8 . The method of claim 1 , wherein said initial double-stranded template nucleic acid molecule is from a human sample.

9 . The method of claim 8 , wherein said human sample comprises tissue.

10 . The method of claim 1 , wherein said plurality of double-stranded amplicons are subjected to an enrichment step where it is captured by a complementary oligonucleotide prior to said paired-end sequencing.

11 . The method of claim 1 , wherein said differentiating said top and bottom strands of said IDSTNM is further based on the observed orientation and order of at least part of said first and second paired-end adapters.

12 . The method of claim 1 , wherein said members of said first family comprise more than two members, and wherein said members of said second family comprise more than two members.

13 . The method of claim 1 , wherein said members of said first family comprise more than five members, and wherein said members of said second family comprise more than five members.

14 . The method of claim 1 , wherein said members of said first family comprise more than ten members, and wherein said members of said second family comprise more than ten members.

Assignees

• Univ Johns Hopkins

Inventors

• Vogelstein Bert
• Kinzler Kenneth W
• Papadopoulos Nickolas
• Kinde Isaac A

Classifications

• C12Q2565/514

  characterised by the use of the arrayed oligonucleotides as identifier tags, e.g. universal addressable array, anti-tag or tag complement array · CPC title

• C12Q2535/122

  Massive parallel sequencing · CPC title

• C12Q1/6874 Primary

  involving nucleic acid arrays, e.g. sequencing by hybridisation · CPC title

• C12Q2600/158

  Expression markers · CPC title

• C12Q2563/179

  the label being a nucleic acid · CPC title